BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18425371)

  • 21. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance.
    Mi Q; Cui B; Lantvit D; Reyes-Lim E; Chai H; Pezzuto JM; Kinghorn AD; Swanson SM
    Anticancer Res; 2003; 23(5A):3607-15. PubMed ID: 14666656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
    Zhao YP; Chen G; Feng B; Zhang TP; Ma EL; Wu YD
    Chin Med J (Engl); 2007 Oct; 120(20):1743-52. PubMed ID: 18028764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation.
    Foroutan B; Zitzelsberger H; Bauer V; Ruf AA; Baumgartner A; Anderson D
    Arch Iran Med; 2011 Sep; 14(5):321-6. PubMed ID: 21888455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal imbalances associated with drug resistance and thermoresistance in human pancreatic carcinoma cells.
    Tönnies H; Lage H
    Eur J Cell Biol; 2004 Oct; 83(10):591-601. PubMed ID: 15679104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance.
    Turton NJ; Judah DJ; Riley J; Davies R; Lipson D; Styles JA; Smith AG; Gant TW
    Oncogene; 2001 Mar; 20(11):1300-6. PubMed ID: 11313874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
    Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
    Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
    Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.
    Dehan E; Ben-Dor A; Liao W; Lipson D; Frimer H; Rienstein S; Simansky D; Krupsky M; Yaron P; Friedman E; Rechavi G; Perlman M; Aviram-Goldring A; Izraeli S; Bittner M; Yakhini Z; Kaminski N
    Lung Cancer; 2007 May; 56(2):175-84. PubMed ID: 17258348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
    Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
    Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codominance of cisplatin resistance in somatic cell hybrids.
    Ying YL; Shen DW; Liang XJ; Gottesman MM
    J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines.
    Wilson C; Yang J; Strefford JC; Summersgill B; Young BD; Shipley J; Oliver T; Lu YJ
    Genes Chromosomes Cancer; 2005 Jun; 43(2):211-6. PubMed ID: 15761863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
    Lips EH; van Eijk R; de Graaf EJ; Oosting J; de Miranda NF; Karsten T; van de Velde CJ; Eilers PH; Tollenaar RA; van Wezel T; Morreau H
    BMC Cancer; 2008 Oct; 8():314. PubMed ID: 18959792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene rearrangement: a novel mechanism for MDR-1 gene activation.
    Mickley LA; Spengler BA; Knutsen TA; Biedler JL; Fojo T
    J Clin Invest; 1997 Apr; 99(8):1947-57. PubMed ID: 9109439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells.
    Cheng TC; Manorek G; Samimi G; Lin X; Berry CC; Howell SB
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):384-95. PubMed ID: 16404635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis.
    Thomassen M; Tan Q; Kruse TA
    Breast Cancer Res Treat; 2009 Jan; 113(2):239-49. PubMed ID: 18293085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification of multidrug resistance related genes in leukemia by suppression subtractive hybridization].
    Zhu NX; Zheng S; Xu RZ; Gao RL; Shen JP; Yu RX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):14-7. PubMed ID: 12679003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
    Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.
    Samimi G; Manorek G; Castel R; Breaux JK; Cheng TC; Berry CC; Los G; Howell SB
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):1-11. PubMed ID: 15378272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.